Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind double-dummy Phase 3 COPD treatment study
2012-002156-16Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Anoro Ellipta in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jul 2014; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-002156-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002156-16.